DASL technology was used to quantify mRNA in samples from @,@ patients enrolled onto the Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer ( North Central Cancer Treatment Group N@ -LSB- NCCTG-N@ -RSB- ) adjuvant trastuzumab trial .